Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

This study will evaluate the safety and tolerability of AGN-199201 for the treatment of erythema associated with rosacea.

Phase 1

Allergan